Results showed that 22% of participants who used varenicline were able to remain abstinent for the full 52 weeks of the study, a rate two-and-a-half times that of the placebo.
Results showed that 22% of participants who used varenicline were able to remain abstinent for the full 52 weeks of the study, a rate two-and-a-half times that of the placebo.
1 comment:
An important addition seems important here. Chantix + ongoing skill building and social support, is the combination that is getting results at 52 weeks. At 6 months, without any social support, the return to smoking rate remains high. I was just in the audience as Dr. Gonzales presented an unpublished study that showed a pattern of slips and relapses for up to 6 months, then stability.
The ongoing studies continue to show us that recovery from tobacco use is a process, not typically a "cessation" event. I think the time is ripe for addiction professionals to enter the tobacco treatment arena. We have much to offer.
Wendy Croze BA, CAC-R, TTS
Post a Comment